Lukas Perkhofer

15PUBLICATIONS
119CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tissue engineeringMolecular targetsPublic health nutritionNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 26, 2026
Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy.

|May 11, 2026
ATM Deficiency Induces TGFβ-Mediated Stromal Programming in Pancreatic Cancer.

|Aug 18, 2025
Homologous Repair-Deficient Pancreatic Cancer: Refined Targeting of DNA Damage Response is an Effective Therapeutic Strategy.

Alica K Beutel, Christopher J Halbrook, Menar Ekizce

|Dec 06, 2024
European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence-based recommendations.

J Enrique Dominguez-Muñoz, Miroslav Vujasinovic, Daniel de la Iglesia

|Jun 06, 2024
Nanoliposomal Irinotecan With Fluorouracil and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Cholangiocarcinoma: A Phase II Study of the AIO Hepatobiliary-YMO Cancer Groups (NIFE-AIO-YMO HEP-0315).

Thomas J Ettrich, Dominik P Modest, Marianne Sinn

|Sep 28, 2023
A Systematic Evaluation of the SARS-CoV-2 Vaccine-Induced Anti-S-RBD-Ig Response in a Population of Health Care Workers.

Viktoria Hentschel, Cornelia Horsch, Benjamin Mayer

Pageof 3

Frequent Collaborators

8 joint publications

Alexander Kleger

5 joint publications

Elodie Roger

5 joint publications

Thomas Jens Ettrich

4 joint publications

Johann Gout